Clinical trials
Not yet recruiting Phase 3 Hypertension trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
7 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2026 | 7 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Not yet recruiting | 7 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ablative Solutions, Inc. | 1 |
| Capital Medical University | 1 |
| EMS | 1 |
| Guangzhou University of Traditional Chinese Medicine | 1 |
| Hanmi Pharmaceutical Company Limited | 1 |
| Uppsala University | 1 |
| Zentiva, k.s. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hypertension | 7 |
| Cerebral Hemorrhage | 1 |
| Edema | 1 |
| Essential Hypertension | 1 |
| Hyperlipidemias | 1 |
| Metabolic Syndrome | 1 |
| Obesity | 1 |
| Overweight | 1 |
| Prediabetic State | 1 |
Trials
Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.